The fungal burden in the liver was not significantly different for the RIB1 deletion strain, however, a decreasing trend over time was observed, which was absent in the wild-type and reintegrant strains (Fig.
← all excerpts
The riboflavin biosynthetic pathway as a novel target for antifungal drugs against <i>Candida</i> species.
1
—
—